CLINICAL
PILOT CLINICAL TRIAL
-
Clinical center: Hospital of Lithuanian University of Health Sciences, Kaunas, Lithuania
-
Patient population: 30 patients (15 treated with ESC, 15 control)
-
The results indicated that the product was safe, simple to use and easily integrated in the surgical protocol
-
The product did not induce any immediate or long-term adverse effects and a trend of efficacy was demonstrated